Verity & Verity, LLC Gilead Sciences, Inc. Transaction History

Verity & Verity, LLC

  • $1.24 Billion
  • Q3 2025

A detailed history of Verity & Verity, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Verity & Verity, LLC holds 270,699 shares of GILD stock, worth $33.6 Million. This represents 2.42% of its overall portfolio holdings.

Number of Shares
270,699
Previous 283,778 4.61%
Holding current value
$33.6 Million
Previous $31.5 Million 4.5%
% of portfolio
2.42%
Previous 2.71%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 21, 2025
SELL
$108.22 - $120.47 $1.42 Million - $1.58 Million
-13,079 Reduced 4.61%
270,699 $30 Million
Q2 2025

Aug 12, 2025
SELL
$96.91 - $113.0 $4.24 Million - $4.95 Million
-43,792 Reduced 13.37%
283,778 $31.5 Million
Q1 2025

Apr 16, 2025
SELL
$89.14 - $117.41 $4.5 Million - $5.93 Million
-50,532 Reduced 13.36%
327,570 $36.7 Million
Q4 2024

Jan 15, 2025
BUY
$83.95 - $97.9 $904,225 - $1.05 Million
10,771 Added 2.93%
378,102 $34.9 Million
Q3 2024

Nov 07, 2024
BUY
$66.59 - $83.99 $1.44 Million - $1.82 Million
21,636 Added 6.26%
367,331 $30.8 Million
Q2 2024

Nov 07, 2024
SELL
$63.15 - $72.88 $142,087 - $163,980
-2,250 Reduced 0.61%
365,081 $25 Million
Q2 2024

Sep 16, 2024
SELL
$63.15 - $72.88 $734,181 - $847,302
-11,626 Reduced 3.25%
345,695 $23.7 Million
Q2 2024

Aug 08, 2024
BUY
$63.15 - $72.88 $17.8 Million - $20.5 Million
281,242 Added 369.67%
357,321 $24.5 Million
Q1 2024

Nov 07, 2024
SELL
$71.58 - $87.29 $2.76 Million - $3.36 Million
-38,513 Reduced 10.48%
328,818 $24.1 Million
Q1 2024

Sep 16, 2024
SELL
$71.58 - $87.29 $3.3 Million - $4.02 Million
-46,108 Reduced 12.9%
311,213 $22.8 Million
Q1 2024

Apr 24, 2024
SELL
$71.58 - $87.29 $18.6 Million - $22.6 Million
-259,342 Reduced 77.32%
76,079 $5.57 Million
Q4 2023

Nov 07, 2024
BUY
$73.27 - $83.09 $90,781 - $102,948
1,239 Added 0.36%
342,546 $27.7 Million
Q4 2023

Feb 12, 2024
BUY
$73.27 - $83.09 $169,400 - $192,104
2,312 Added 0.69%
335,421 $27.2 Million
Q3 2023

Nov 07, 2024
SELL
$73.94 - $80.67 $1.92 Million - $2.1 Million
-26,024 Reduced 7.08%
341,307 $25.6 Million
Q3 2023

Oct 19, 2023
BUY
$73.94 - $80.67 $200,229 - $218,454
2,708 Added 0.82%
333,109 $25 Million
Q2 2023

Nov 07, 2024
SELL
$76.01 - $86.7 $2.29 Million - $2.61 Million
-30,155 Reduced 8.21%
337,176 $26 Million
Q2 2023

Jul 10, 2023
BUY
$76.01 - $86.7 $1.32 Million - $1.5 Million
17,353 Added 5.54%
330,401 $25.5 Million
Q1 2023

Nov 07, 2024
SELL
$77.31 - $88.08 $3.68 Million - $4.19 Million
-47,608 Reduced 12.96%
319,723 $26.5 Million
Q1 2023

May 02, 2024
BUY
$77.31 - $88.08 $18.3 Million - $20.9 Million
236,969 Added 311.48%
313,048 $26 Million
Q1 2023

Apr 03, 2023
SELL
$77.31 - $88.08 $229,533 - $261,509
-2,969 Reduced 0.94%
313,048 $26 Million
Q4 2022

Jan 11, 2023
SELL
$62.32 - $89.47 $223,105 - $320,302
-3,580 Reduced 1.12%
316,017 $0
Q3 2022

Oct 24, 2022
BUY
$59.54 - $68.01 $592,958 - $677,311
9,959 Added 3.22%
319,597 $19.7 Million
Q2 2022

Jun 30, 2022
SELL
$57.72 - $65.01 $173,333 - $195,225
-3,003 Reduced 0.96%
309,638 $19.1 Million
Q1 2022

May 03, 2022
BUY
$57.92 - $72.58 $5.95 Million - $7.45 Million
102,665 Added 48.89%
312,641 $18.6 Million
Q4 2021

Feb 01, 2022
BUY
$64.88 - $73.64 $327,838 - $372,102
5,053 Added 2.47%
209,976 $15.2 Million
Q3 2021

Nov 04, 2021
BUY
$67.69 - $73.03 $611,376 - $659,606
9,032 Added 4.61%
204,923 $13.8 Million
Q1 2021

Jun 21, 2021
BUY
$60.0 - $68.46 $2.61 Million - $2.97 Million
43,431 Added 28.49%
195,891 $13 Million
Q4 2020

Jan 12, 2021
BUY
$56.65 - $64.55 $1.1 Million - $1.26 Million
19,497 Added 14.66%
152,460 $9.53 Million
Q3 2020

Oct 06, 2020
BUY
$62.1 - $78.08 $2.37 Million - $2.98 Million
38,200 Added 40.31%
132,963 $8.46 Million
Q2 2020

Jul 14, 2020
BUY
$72.34 - $84.0 $144,101 - $167,328
1,992 Added 2.15%
94,763 $7.27 Million
Q1 2020

Apr 09, 2020
BUY
$62.63 - $80.22 $2.03 Million - $2.61 Million
32,490 Added 53.9%
92,771 $6.94 Million
Q4 2019

Jan 08, 2020
BUY
$61.62 - $67.78 $2.2 Million - $2.42 Million
35,721 Added 145.44%
60,281 $3.92 Million
Q3 2019

Oct 11, 2019
BUY
$62.51 - $69.0 $1.54 Million - $1.69 Million
24,560 New
24,560 $1.52 Million

Others Institutions Holding GILD

# of Institutions
2,367
Shares Held
1.01B
Call Options Held
8.58M
Put Options Held
7.35M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $156B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Verity & Verity, LLC Portfolio

Follow Verity & Verity, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verity & Verity, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verity & Verity, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email